ERG and neoplasm: A patient was considered heterogeneous for ERG immunostaining if different tumor foci had different ERG results (interfocal heterogeneity) or if at least one tumor focus showed a mixture of ERG positive and ERG negative tumor cells (intrafocal heterogeneity).